Hopeful of launching Covovax for adults in October this year, for children in Q1-2022, says Serum CEO
The Hindu
It will be a two-dose vaccine and the price will be decided at the time of launch, Adar Poonawalla added.
Serum Institute of India CEO Adar Poonawalla on Friday said he is hopeful that Covovax, another COVID-19 vaccine being manufactured by his company in India, will be launched in October for adults and for children by the first quarter of 2022. He also thanked the government for all the support provided to Serum Institute and said the company is always trying to expand its Covishield production capacity to meet the demand. Mr. Poonawalla met Home Minister Amit Shah in Parliament and the meeting between the two lasted for 30 minutes.More Related News
Autopsy report of Manipur family says victims were shot multiple times before bodies dumped in river
The autopsy report of three of the six members of a Meitei family who were allegedly abducted by armed militants during an encounter with security forces in Jiribam district of Manipur on November 11, 2024, reveals that they were shot multiple times before their bodies were dumped in a river.